A placebo-controlled trial found that semaglutide reduced pulmonary artery wedge pressure during low-intensity exercise in people with heart failure with preserved ejection fraction and obesity.
Semaglutide Lowers Heart Pressure During Exercise in Obese Patients With Heart Failure
A placebo-controlled trial found that semaglutide reduced pulmonary artery wedge pressure during low-intensity exercise in people with heart failure with preserved ejection fraction and obesity.
Dennis Sylvester Hurd · Public domain · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.